SERA PROGNOSTICS, INC. Logo

SERA PROGNOSTICS, INC.

Develops predictive blood tests to assess preterm birth risk and improve pregnancy outcomes.

SERA | US

Overview

Corporate Details

ISIN(s):
US81749D1072
LEI:
Country:
United States of America
Address:
2749 E. PARLEYS WAY, 84109 SALT LAKE CITY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sera Prognostics, Inc., also known as The Pregnancy Company®, is a women's health diagnostics company focused on improving maternal and neonatal health through precision pregnancy care. The company utilizes proteomics and bioinformatics to develop and commercialize predictive biomarker tests. Its flagship product, the PreTRM® Test, is a blood-based test that predicts an individual's risk of spontaneous preterm delivery. Sera also offers the LikeMine™ platform, which provides data-driven pregnancy insights for mothers. By delivering pivotal information to physicians, payers, and patients, Sera aims to improve health outcomes and economics in prenatal care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SERA PROGNOSTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SERA PROGNOSTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SERA PROGNOSTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AMARIN CORP PLC\UK Logo
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
United States of America AMRN
AMGEN INC Logo
Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.
United States of America AMGN
Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
South Korea 092040
AMICUS THERAPEUTICS, INC. Logo
Develops advanced therapies for rare lysosomal storage disorders.
United States of America FOLD
AMINOLOGICS CO.,LTD. Logo
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea 074430
Amneal Pharmaceuticals, Inc. Logo
Develops & commercializes essential medicines: generics, injectables & specialty drugs.
United States of America AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.
United States of America AMPH
Amylyx Pharmaceuticals, Inc. Logo
Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.
United States of America AMLX
AN2 Therapeutics, Inc. Logo
Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.
United States of America ANTX
Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom ANAN

Talk to a Data Expert

Have a question? We'll get back to you promptly.